FDA ClearsAISoftware for Assessing Intracerebral Hemorrhage on Non-Contrast CT
Diagnostic Imaging“Verification of MRI/CT results with18F FDG-PET-CT seems useful to identify patients at highriskof metastasis, particularly in cases with …
Read the original at diagnosticimaging.com ↗
- Topics
- Healthcare
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”